OM:BONEX
OM:BONEXBiotechs

Evaluating Bonesupport Holding (OM:BONEX) Valuation Following Strong Clinical Results for CERAMENT® G in Hip Infection Study

For investors keeping an eye on Bonesupport Holding (OM:BONEX), the latest news might feel like a pivotal moment. The company just announced positive clinical data for its CERAMENT® G product, which showed significantly improved patient outcomes in a high-risk hip infection population. What stands out is that not a single patient experienced a re-infection during the two-year follow-up. This is an impressive departure from much higher industry averages and could be a potential signal that...
OM:YUBICO
OM:YUBICOSoftware

Will Yubico's (OM:YUBICO) New Leadership Team Reshape Its Long-Term Competitive Position?

Yubico recently announced the appointments of Albert Biketi as Chief Product and Technology Officer and Sheryl Chamberlain as Senior Vice President of Business Development, adding two seasoned leaders with deep expertise in cybersecurity, technology, and partnership management. This executive team expansion follows the hire of a new CFO, marking a focused effort by Yubico to strengthen its management team to support its global ambitions and drive innovation in secure digital...